Tag: tenosynovial giant cell tumor treatment

Home / tenosynovial giant cell tumor treatment

Categories

Vimseltinib is approved by the USFDA for symptomatic tenosynovial giant cell tumor

On February 14, 2025, the Food and Drug Administration sanctioned vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cel...
tenosynovial-giant-cell-tumor-treatment

Scan the code